Immediate Impact
11 by Nobel laureates 24 from Science/Nature 63 standout
Citing Papers
General access to cubanes as benzene bioisosteres
2023 StandoutNature
Zwitterionic Biomaterials
2022 Standout
Works of Alexander MacDonald being referenced
A phase I, open-label, first-time-in-patient dose escalation and expansion study to assess the safety, tolerability, and pharmacokinetics of nanoparticle encapsulated Aurora B kinase inhibitor AZD2811 in patients with advanced solid tumours.
2017
Discovery of carmegliptin: A potent and long-acting dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes
2009
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Alexander MacDonald | 279 | 295 | 292 | 53 | 868 | |
| Yanhua Zeng | 186 | 195 | 307 | 55 | 801 | |
| Leslie C. Norins | 142 | 255 | 383 | 35 | 938 | |
| M.Robert Lifely | 454 | 249 | 227 | 24 | 973 | |
| B. Mansa | 306 | 235 | 143 | 53 | 922 | |
| J. Goudswaard | 311 | 350 | 109 | 54 | 1.1k | |
| Wenjia Sun | 378 | 218 | 256 | 38 | 919 | |
| E. Ruuth | 276 | 249 | 155 | 32 | 896 | |
| John L. Cantrell | 377 | 632 | 130 | 41 | 1.1k | |
| Hilda Garay | 509 | 274 | 277 | 66 | 1.0k | |
| Jan Kolberg | 294 | 184 | 585 | 55 | 1.0k |
All Works
Loading papers...